These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23663994)

  • 1. Trends and determinants of use of long-acting reversible contraception use among young women in France: results from three national surveys conducted between 2000 and 2010.
    Moreau C; Bohet A; Hassoun D; Teboul M; Bajos N;
    Fertil Steril; 2013 Aug; 100(2):451-8. PubMed ID: 23663994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of long-acting reversible contraception use among unmarried young adults.
    Dempsey AR; Billingsley CC; Savage AH; Korte JE
    Am J Obstet Gynecol; 2012 Jun; 206(6):526.e1-5. PubMed ID: 22425402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postabortion Initiation of Long-Acting Reversible Contraception by Adolescent and Nulliparous Women in New Zealand.
    Rose SB; Garrett SM
    J Adolesc Health; 2016 Feb; 58(2):160-6. PubMed ID: 26603946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
    Law A; Pilon D; Lynen R; Laliberté F; Gozalo L; Lefebvre P; Duh MS
    Reprod Health; 2016 Aug; 13(1):96. PubMed ID: 27549429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of users of intrauterine devices and other reversible contraceptive methods in the United States.
    Xu X; Macaluso M; Frost J; Anderson JE; Curtis K; Grosse SD
    Fertil Steril; 2011 Nov; 96(5):1138-44. PubMed ID: 21917255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IUD use in France: women's and physician's perspectives.
    Moreau C; Bohet A; Hassoun D; Ringa V; Bajos N;
    Contraception; 2014 Jan; 89(1):9-16. PubMed ID: 24239330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of long-acting reversible contraceptive (LARC) use by adolescent girls and young women.
    Bharadwaj P; Akintomide H; Brima N; Copas A; D'Souza R
    Eur J Contracept Reprod Health Care; 2012 Aug; 17(4):298-306. PubMed ID: 22758602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes toward long-acting reversible contraception among young women seeking abortion.
    Rose SB; Cooper AJ; Baker NK; Lawton B
    J Womens Health (Larchmt); 2011 Nov; 20(11):1729-35. PubMed ID: 21923281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge and Acceptability of Long-Acting Reversible Contraception Among Adolescent Women Receiving School-Based Primary Care Services.
    Hoopes AJ; Ahrens KR; Gilmore K; Cady J; Haaland WL; Amies Oelschlager AM; Prager S
    J Prim Care Community Health; 2016 Jul; 7(3):165-70. PubMed ID: 27067583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the Use of Long-Acting Reversible Contraceptive Methods Among U.S. Nulliparous Women: Results from the 2006-2010, 2011-2013, and 2013-2015 National Survey of Family Growth.
    Ihongbe TO; Masho SW
    J Womens Health (Larchmt); 2018 Mar; 27(3):245-252. PubMed ID: 29148890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awareness of long-acting reversible contraception among teens and young adults.
    Teal SB; Romer SE
    J Adolesc Health; 2013 Apr; 52(4 Suppl):S35-9. PubMed ID: 23535055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder.
    Matusiewicz AK; Melbostad HS; Heil SH
    Contraception; 2017 Nov; 96(5):365-369. PubMed ID: 28778423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics associated with interest in long-acting reversible contraception in a postpartum population.
    Tang JH; Dominik R; Re S; Brody S; Stuart GS
    Contraception; 2013 Jul; 88(1):52-7. PubMed ID: 23158805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of use of long-acting reversible methods of contraception among adolescent and young adult women.
    Whitaker AK; Dude AM; Neustadt A; Gilliam ML
    Contraception; 2010 Apr; 81(4):299-303. PubMed ID: 20227545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting reversible contraception: a practical solution to reduce unintended pregnancy.
    Secura G
    Minerva Ginecol; 2013 Jun; 65(3):271-7. PubMed ID: 23689169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.
    Rafie S; McIntosh J; Shealy KM; Borgelt LM; Forinash A; Shrader SP; Koepf ER; McClendon KS; Griffin BL; Horlen C; Karaoui LR; Rowe EL; Lodise NM; Wigle PR
    Pharmacotherapy; 2014 Sep; 34(9):991-9. PubMed ID: 24989020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting reversible contraception: a review in special populations.
    Prescott GM; Matthews CM
    Pharmacotherapy; 2014 Jan; 34(1):46-59. PubMed ID: 24130075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized contraceptive assistance and uptake of long-acting, reversible contraceptives by postpartum women: a randomized, controlled trial.
    Simmons KB; Edelman AB; Li H; Yanit KE; Jensen JT
    Contraception; 2013 Jul; 88(1):45-51. PubMed ID: 23218851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends and determinants of IUD use in the USA, 2002-2012.
    Mosher WD; Moreau C; Lantos H
    Hum Reprod; 2016 Aug; 31(8):1696-702. PubMed ID: 27251204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting reversible contraceptive use in the post-abortion period among women seeking abortion in mainland China: intentions and barriers.
    Luo Z; Gao L; Anguzu R; Zhao J
    Reprod Health; 2018 May; 15(1):85. PubMed ID: 29793501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.